PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31023764-1	2019	INTRODUCTION AND AIMS: Esmolol is an ultra-short-acting beta1 antagonist that has been shown to attenuate the corrected QT (QTc) interval prolongation associated with laryngoscopy and endotracheal intubation (LTI).	esmolol	23-30	BCL2 related protein A1	Homo sapiens	56-61	
34136985-3	2021	The current study was conducted to investigate the cytotoxic and apoptotic effects of beta-1 selective esmolol, beta-2 selective ICI-118,551, and non-selective nadolol blockers on the cancerous and healthy lung cells.	esmolol	103-110	BCL2 related protein A1	Homo sapiens	86-92	
33831899-1	2021	BACKGROUND: Esmolol is a beta-1 selective blocker that has been shown to reduce postoperative pain.	esmolol	12-19	BCL2 related protein A1	Homo sapiens	25-31